SALUDA MEDICAL, INC. ARBN 691 140 360 9401 James Ave S, Suite 132 Bloomington MN 55431, United States 1 10 September 2026 Saluda Medical, Inc. Consolidated Financial Statements for the year ended 30 June 2026 Saluda Medical, Inc. (ASX:SLD, “Saluda” or the “Company”), today released its...
FY26 Consolidated Financial Statements
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Saluda Medical
- CEO Transition
- S&P DJI Announces September 2026 Quarterly Rebalance
- Change in substantial holding
- FY26 Results Presentation
- FY26 Full Year Results
Later from Saluda Medical
- Final Director's Interest Notice - B Regan
- Director Appointment/Resignation
- Initial Director's Interest Notice
- Expands Access with Full US Commercial Release of CAP24
- Notification regarding unquoted securities - SLD
Follow Saluda Medical into a list and get an email when it puts out news.
Follow Saluda Medical